193 related articles for article (PubMed ID: 3096991)
1. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
Ramesha CS; Pickett WC
J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991
[TBL] [Abstract][Full Text] [Related]
2. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.
Chilton FH; Ellis JM; Olson SC; Wykle RL
J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535
[TBL] [Abstract][Full Text] [Related]
3. Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils.
Chilton FH; O'Flaherty JT; Ellis JM; Swendsen CL; Wykle RL
J Biol Chem; 1983 Jun; 258(12):7268-71. PubMed ID: 6408071
[TBL] [Abstract][Full Text] [Related]
4. Metabolic fate of platelet-activating factor in neutrophils.
Chilton FH; O'Flaherty JT; Ellis JM; Swendsen CL; Wykle RL
J Biol Chem; 1983 May; 258(10):6357-61. PubMed ID: 6853486
[TBL] [Abstract][Full Text] [Related]
5. Conversion of 1-O-[3H]alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils.
Venable ME; Nieto ML; Schmitt JD; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18691-8. PubMed ID: 1917993
[TBL] [Abstract][Full Text] [Related]
6. Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).
Triggiani M; Chilton FH
Biochim Biophys Acta; 1989 Nov; 1006(1):41-51. PubMed ID: 2572273
[TBL] [Abstract][Full Text] [Related]
7. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
9. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product.
Malone B; Lee T; Snyder F
J Biol Chem; 1985 Feb; 260(3):1531-4. PubMed ID: 3918041
[TBL] [Abstract][Full Text] [Related]
11. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells.
Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A
J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
13. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes.
Sugiura T; Fukuda T; Masuzawa Y; Waku K
Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
Chepenik KP; Wykle RL
Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622
[TBL] [Abstract][Full Text] [Related]
15. Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages.
Albert DH; Snyder F
Biochim Biophys Acta; 1984 Oct; 796(1):92-101. PubMed ID: 6435681
[TBL] [Abstract][Full Text] [Related]
16. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
17. Ether phospholipids in control and 20:4-depleted rat PMN: additional evidence for a 1-O-alkyl-2-20:4-sn-glycerol-3-phosphocholine specific phospholipase A2.
Pickett WC; Ramesha CS
Agents Actions; 1987 Aug; 21(3-4):390-2. PubMed ID: 3120515
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis and metabolism of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in rat glomerular mesangial cells.
Lianos EA; Zanglis A
J Biol Chem; 1987 Jul; 262(19):8990-3. PubMed ID: 3110152
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of platelet-activating factor in the guinea-pig heart.
Triggiani M; Chilton FH
J Mol Cell Cardiol; 1992 Oct; 24(10):1101-11. PubMed ID: 1479612
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic studies of lyso platelet-activating factor acylation in human neutrophils and changes upon stimulation.
Venable ME; Olson SC; Nieto ML; Wykle RL
J Biol Chem; 1993 Apr; 268(11):7965-75. PubMed ID: 8463317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]